I honestly read this as some kind of competition we're trying to recognize is the world's biggest face. Like a person with a giant face.

There's not typically a problem with the pharmacokinetics, where additional benefit can potentially be extracted from alternative delivery methods. If the oral route works, that's almost always the best way to go.

Typically, it's an expensive proposition to study unnecessary delivery methods, especially when user error can become a problem, this complicates the path to market. Typically, there's not a lot of benefit to the extracted from just testing every type of delivery.

If oral delivery poses certain challenges, then other methods can be explored.

Crush into pink goo for post Holiday indigestion